Workflow
BIOVAXYS ANNOUNCES SHARE CONSOLIDATION
Prnewswire·2025-09-06 05:00

The Company anticipates its Common Shares will commence trading on a post-Consolidation basis on the Canadian Securities Exchange (the "CSE") at market open on September 11, 2025. The new CUSIP number for the post-Consolidation Common Shares will be 09076M200Â and the new ISIN number will be CA09076M2004. The name of the Company and trading symbol will remain the same after the Consolidation. The Company currently has 293,425,203 Common Shares issued and outstanding. Following the Consolidation, the Company ...